共 50 条
- [2] Usefulness of TAS-102 as Third-line Chemotherapy for Metastatic Colorectal Cancer [J]. CANCER SCIENCE, 2018, 109 : 601 - 601
- [3] Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study [J]. International Journal of Clinical Oncology, 2021, 26 : 111 - 117
- [9] Case Report: Anlotinib Combined With Sintilimab as Third-Line Treatment in a Metastatic Urothelial Bladder Carcinoma Patient With FGFR3 Mutation [J]. FRONTIERS IN ONCOLOGY, 2021, 11